Sign In
Book a Demo
Dr. Bruno Carneiro De Medeiros, MD
About ProfilePoints™
0 Patient Reviews

Dr. Bruno Carneiro De Medeiros, MD

Hematology / Oncology Specialist - Hematologist (Blood)

Highlights

  • Board Certified
  • Accepts Insurance Plans

Biography

Dr. Bruno Carneiro De Medeiros, MD is a Hematology / Oncology Specialist - Hematologist (Blood) practicing in Palo Alto, CA

He has not yet shared a personalized biography with Doctor.com.

View Phone #Call Now

Are you Dr. Bruno Carneiro De Medeiros, MD?

Claim your 100% free Doctor.com profile to:

  • Respond to patient reviews
  • Customize your profile
  • Improve your visibility to our millions of monthly users
Claim your profile

Provider Training

UniversityDegreeFocusGraduated
Federal University of ParanaMedical DegreeNot Specified

InstitutionFocusYear
Internship - University of Connecticut Health Center CT 2000
Internship - University of Connecticut Health Center2000
Residency - University of Colorado Health Science Center2002
Residency - University of Colorado Denver Affiliated Hospitals2002
Fellowship - Acute leukemia, Princess Margaret Hospital - University of Toronto 2006
Fellowship - University of Colorado Health Science Center CO 2005
Fellowship - Acute leukemia, Princess Margaret Hospital - University of Toronto2006

CertificationCert. BodyYear

Sub-Specialty: Hematology		Internal Medicine2006

Sub-Specialty: Medical Oncology		Internal Medicine2005
Internal medicine
Sub-Specialty: Hematology		Internal Medicine2006
Internal medicine
Sub-Specialty: Medical Oncology		Internal Medicine2005

Experience & Accolades

PositionOrganizationTime
Panel Member Multiple Myeloma Committee, National Comprehensive Cancer Network
2007 - 2011
Director Stanford Hospital Hematology Inpatient service
2011 - 2013
Director Stanford Acute Leukemia Clinical Research Program
2009 - 2013
Panel member adult oncology committee, National comprehensive cancer network
2010 - 2013
Acute Leukemia Panel Member Southwest Oncology Group
2007 - 2013
Assistant Professor of Medicine (Hematology)the Stanford University Medical Center
Present

Publication Publisher Title Published
Other PublicationProceedings of the National Academy of Sciences of the United States oPreleukemic mutations in human acute myeloid leukemia affect epigenetic regulators2014
Other PublicationBRITISH JOURNAL OF HAEMATOLOGYUnsuccessful diagnostic cytogenetic analysis is a poor prognostic feature2014
Other PublicationHaematologicaSequential azacitidine plus lenalidomide combination2013
Other PublicationHAEMATOLOGICA-THE HEMATOLOGY JOURNALImpact of body-mass index on the outcome of adult patients with acute myeloid leukemia2012
Other PublicationBLOODBlood consult: monosomal karyotype acute myeloid leukemia2012
Other PublicationLEUKEMIASafety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide2012
Other PublicationCANCERImpact of residual normal metaphases in core binding factor acute myeloid leukemia2012
Other PublicationBloodUnveiling the complexity of CK+ AML.2012
Other PublicationAMERICAN JOURNAL OF HEMATOLOGYTailored temozolomide therapy according to MGMT methylation status2012
Other PublicationNEW ENGLAND JOURNAL OF MEDICINECytarabine Dose for Acute Myeloid Leukemia2011
Other PublicationBLOODPrognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia2010
Other PublicationLEUKEMIA RESEARCHMcl-1 dependence predicts response to vorinostat2014
Other PublicationJournal of the National Comprehensive Cancer NetworkSenior adult oncology, version 2.2014: clinical practice guidelines in oncology .2014
Other PublicationActa haematologicaFacts about FCE (Fludarabine, Cytarabine, Etoposide) in Acute Myeloid Leukemia.2014
Other PublicationHAEMATOLOGICAGemtuzumab ozogamicin in combination with vorinostat2014
Other PublicationJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKHematopoietic Stem Cell Transplantation for Hematologic Malignancies in Older Adults2014
Other PublicationJournal of oncology practice / American Society of Clinical OncologyQualitative analysis of practicing oncologists' attitudes2013
Other PublicationLeukemia & lymphomaA single-center experience of the nationwide daunorubicin shortage2013
Other PublicationLEUKEMIA RESEARCHCD11b expression and MK+ AML: A sign of impending doom?2013
Other PublicationLEUKEMIA & LYMPHOMA2-Hydroxyglutarate in IDH mutant acute myeloid leukemia2013
Other PublicationLEUKEMIACD19(-)CD45(low/-)CD38(high)/CD138(+) plasma cells enrich for human tumorigenic myeloma cells2012
Other PublicationDinner, S. N., Dunn, T. J., Medeiros, B. C., Coutre, S. E., Berube, C.Amrubicin, a Novel Investigational Anthracycline
Other PublicationBecker, P. S., Medeiros, B. C., Stein, A. S., Appelbaum, F. R., Scott,Multicenter Phase 2 Trial of G-CSF Priming, Clofarabine
Other PublicationDunn, T. J., Dinner, S. N., Berube, C., Gotlib, J., Coutre, S. E., MedA Phase I/II Study of Bortezomib
Other PublicationHEMATOLOGYHemophagocytic lymphohistiocytosis in pregnancy: a case report and review of treatment options2012
Other PublicationJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKWaldenstrom's Macroglobulinemia2012
Other PublicationJournal of the National Comprehensive Cancer NetworkWaldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.2012
Other PublicationAMERICAN JOURNAL OF HEMATOLOGYAbsolute lymphocyte count at day 28 independently predicts event-free2012
Other PublicationINTERNATIONAL JOURNAL OF HEMATOLOGYNovel agents in acute myeloid leukemia2012
Other PublicationJOURNAL OF GERIATRIC ONCOLOGYNew treatment approaches for older adults with multiple myeloma2012
Other PublicationHAEMATOLOGICA-THE HEMATOLOGY JOURNALPhase II trial of vorinostat and gemtuzumab ozogamicin as induction and post2012
Other PublicationAPPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGYAggressive EBV-associated Lymphoproliferative Disorder2012
Other PublicationJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKSenior Adult Oncology2012
Other PublicationLEUKEMIA RESEARCHIt doesn't matter if you're black or white, does it?2012
Other PublicationHAEMATOLOGICA-THE HEMATOLOGY JOURNALPhase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B2012
Other PublicationHAEMATOLOGICA-THE HEMATOLOGY JOURNALTreatment advances have not improved the early death rate in acute promyelocytic leukemia2012
Other PublicationBecker, P. S., Medeiros, B. C., Appelbaum, F. R., Scott, B. L., HendriPhase 2 Trial of G-CSF Priming, Clofarabine2011
Other PublicationJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKMultiple Myeloma2011
Other PublicationEXPERT REVIEW OF HEMATOLOGYUnfavorable-risk cytogenetics in acute myeloid leukemia2011
Other PublicationEXPERT OPINION ON THERAPEUTIC TARGETSTargeting protein neddylation: a novel therapeutic strategy for the treatment of cancer2011
Other PublicationBRITISH JOURNAL OF HAEMATOLOGYAcute myeloid leukaemia in the elderly: a review2011
Other PublicationLAB ON A CHIPMicrofluidic purification and analysis of hematopoietic stem cells from bone marrow2011
Other PublicationPollyea, D. A., Kohrt, H. E., Gallegos, L., Berube, C., Coutre, S., GoA Phase I Study of Sequential Azacitidine2010
Other PublicationMedeiros, B. C., Kohrt, H. E., Rajwanshi, R., Gotlib, J., Coutre, S., Temozolomide In Acute Myeloid Leukemia2010
Other PublicationAMERICAN JOURNAL OF HEMATOLOGYSecond-line mitoxantrone, etoposide2010
Other PublicationExpert review of hematologyPlasma cell leukemia: concepts and management.2010
Other PublicationEXPERT REVIEW OF HEMATOLOGYPlasma cell leukemia: concepts and management2010
Other PublicationAMERICAN JOURNAL OF HEMATOLOGYMyelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with2010
Other PublicationWalter, B., Medeiros, B., Nielsen-Stoeck, M., Harrington, E., Powell, PHASE 2 TRIAL OF VORINOSTAT2010
Other PublicationLEUKEMIA RESEARCHImmunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2)2010
Other PublicationAlizadeh, A. A., McClellan, J. S., Gotlib, J. R., Coutre, S., Majeti, Early Mortality in Acute Promyelocytic Leukemia May Be Higher Than Previously Reported.2009
Other PublicationKohrt, H. E., Patel, S., Ho, M., Owen, T., Majeti, R., Gotlib, J. R., Is Time of the Essence in Adult Acute Myeloid Leukemia2009
Other PublicationJOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKMultiple Myeloma2009
Other PublicationAMERICAN JOURNAL OF HEMATOLOGYThalidomide-induced pneumonitis in a patient with plasma cell leukemia2009
Other PublicationJournal of the National Comprehensive Cancer NetworkNCCN clinical practice guidelines in oncology: multiple myeloma.2009
Other PublicationMedeiros, B. C., Gotlib, J. R., Coutre, S. E., Jones, C., Khan, S. A.,Interim results of protracted low doses of temozolomide in high-risk acute myeloid leukemia
Other PublicationNEW ENGLAND JOURNAL OF MEDICINEDeletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia2009
Other PublicationJOURNAL OF CLINICAL ONCOLOGYRole of CEBPA in Normal Karyotype Acute Myeloid Leukemia2009
Other PublicationJOURNAL OF CLINICAL ONCOLOGYComparing Apples and Oranges in Normal Karyotype Acute Myeloid Leukemia2009
Other PublicationMcGuire, A., Shier, L. R., Gotlib, J., Medeiros, B., Wong, K., CorlessMyelomastocytic Leukemia: A Clinical, Pathologic, and Molecular Genetic Study2009
Other PublicationCases journalComplete remission of primary plasma cell leukemia with bortezomib, doxorubicin2009
Other PublicationProceedings of the tiol Academy of Sciences of the United States of AmPreleukemic mutations in human acute myeloid leukemia affect epigenetic regulators2014
Other PublicationBRITISH JOURL OF HAEMATOLOGYUnsuccessful diagnostic cytogenetic alysis is a poor prognostic feature in acute myeloid leukaemia2014
Other PublicationHaematologicaSequential azacitidine plus lelidomide combition2013
Other PublicationHAEMATOLOGICA-THE HEMATOLOGY JOURLImpact of body-mass index on the outcome of adult patients with acute myeloid leukemia2012
Other PublicationLEUKEMIASafety, efficacy and biological predictors of response to sequential azacitidine and lelidomide for2012
Other PublicationAMERICAN JOURL OF HEMATOLOGYTailored temozolomide therapy according to MGMT methylation status2012
Other PublicationNEW ENGLAND JOURL OF MEDICINECytarabine Dose for Acute Myeloid Leukemia2011
Other PublicationJourl of the tiol Comprehensive Cancer NetworkSenior adult oncology, version 2.2014: clinical practice guidelines in oncology .2014
Other PublicationHAEMATOLOGICAGemtuzumab ozogamicin in combition with vorinostat2014
Other PublicationJOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKHematopoietic Stem Cell Transplantation for Hematologic Maligncies in Older Adults2014
Other PublicationJourl of oncology practice / American Society of Clinical OncologyQualitative alysis of practicing oncologists' attitudes2013
Other PublicationLeukemia & lymphomaA single-center experience of the tionwide daunorubicin shortage2013
Other PublicationDinner, S. N., Dunn, T. J., Medeiros, B. C., Coutre, S. E., Berube, C.Amrubicin, a Novel Investigatiol Anthracycline
Other PublicationDunn, T. J., Dinner, S. N., Berube, C., Gotlib, J., Coutre, S. E., MedA Phase I/II Study of Bortezomib
Other PublicationHEMATOLOGYHemophagocytic lymphohistiocytosis in pregncy: a case report and review of treatment options2012
Other PublicationJOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKWaldenstrom's Macroglobulinemia2012
Other PublicationJourl of the tiol Comprehensive Cancer NetworkWaldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.2012
Other PublicationAMERICAN JOURL OF HEMATOLOGYAbsolute lymphocyte count at day 28 independently predicts event-free2012
Other PublicationINTERTIOL JOURL OF HEMATOLOGYNovel agents in acute myeloid leukemia2012
Other PublicationJOURL OF GERIATRIC ONCOLOGYNew treatment approaches for older adults with multiple myeloma2012
Other PublicationHAEMATOLOGICA-THE HEMATOLOGY JOURLPhase II trial of vorinostat and gemtuzumab ozogamicin as induction and post2012
Other PublicationJOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKSenior Adult Oncology2012
Other PublicationHAEMATOLOGICA-THE HEMATOLOGY JOURLPhase I trial of a novel human monoclol antibody mAb216 in patients with relapsed or refractory B2012
Other PublicationHAEMATOLOGICA-THE HEMATOLOGY JOURLTreatment advances have not improved the early death rate in acute promyelocytic leukemia2012
Other PublicationJOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKMultiple Myeloma2011
Other PublicationBRITISH JOURL OF HAEMATOLOGYAcute myeloid leukaemia in the elderly: a review2011
Other PublicationLAB ON A CHIPMicrofluidic purification and alysis of hematopoietic stem cells from bone marrow2011
Other PublicationPollyea, D. A., Kohrt, H. E., Gallegos, L., Berube, C., Coutre, S., GoA Phase I Study of Sequential Azacitidine2010
Other PublicationAMERICAN JOURL OF HEMATOLOGYSecond-line mitoxantrone, etoposide2010
Other PublicationExpert review of hematologyPlasma cell leukemia: concepts and magement.2010
Other PublicationEXPERT REVIEW OF HEMATOLOGYPlasma cell leukemia: concepts and magement2010
Other PublicationAMERICAN JOURL OF HEMATOLOGYMyelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with2010
Other PublicationWalter, B., Medeiros, B., Nielsen-Stoeck, M., Harrington, E., Powell, PHASE 2 TRIAL OF VORINOSTAT2010
Other PublicationJOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKMultiple Myeloma2009
Other PublicationAMERICAN JOURL OF HEMATOLOGYThalidomide-induced pneumonitis in a patient with plasma cell leukemia2009
Other PublicationJourl of the tiol Comprehensive Cancer NetworkNCCN clinical practice guidelines in oncology: multiple myeloma.2009
Other PublicationNEW ENGLAND JOURL OF MEDICINEDeletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia2009
Other PublicationJOURL OF CLINICAL ONCOLOGYRole of CEBPA in Normal Karyotype Acute Myeloid Leukemia2009
Other PublicationJOURL OF CLINICAL ONCOLOGYComparing Apples and Oranges in Normal Karyotype Acute Myeloid Leukemia2009
Other PublicationCases jourlComplete remission of primary plasma cell leukemia with bortezomib, doxorubicin2009

Practice & Hospital Affiliations

Dr. Bruno Carneiro De Medeiros, MD has not yet indicated the hospitals that he is affiliated with.

Photos

Provider Profile 0Provider Profile 1Provider Profile 2

Specialties

Languages Spoken
English, Portuguese
Medical Specialties
  • Hematology / Oncology Specialist - Sub-Specialty: Hematologist (Blood)

Accepts New Patients: Yes

Accepted Insurance

Full Insurance List

Payment Options

Payment Details
We use cookies and limited processing of your personal information for our website and services to function. By using our site, you agree to our use of cookies and our privacy policy.
I Accept